Samsung Biologics Co Ltd
KRX:207940
Samsung Biologics Co Ltd
EPS (Diluted)
Samsung Biologics Co Ltd
EPS (Diluted) Peer Comparison
Competitive EPS (Diluted) Analysis
Latest Figures & CAGR of Competitors
Company | EPS (Diluted) | CAGR 3Y | CAGR 5Y | CAGR 10Y | |
---|---|---|---|---|---|
Samsung Biologics Co Ltd
KRX:207940
|
EPS (Diluted)
₩12.1k
|
CAGR 3-Years
49%
|
CAGR 5-Years
29%
|
CAGR 10-Years
N/A
|
|
P
|
Peptron Inc
KOSDAQ:087010
|
EPS (Diluted)
-₩773
|
CAGR 3-Years
13%
|
CAGR 5-Years
-27%
|
CAGR 10-Years
N/A
|
K
|
Knotus Co Ltd
KOSDAQ:278650
|
EPS (Diluted)
-₩2
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
S
|
ST Pharm Co Ltd
KOSDAQ:237690
|
EPS (Diluted)
₩1k
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
F
|
FutureChem Co Ltd
KOSDAQ:220100
|
EPS (Diluted)
-₩303
|
CAGR 3-Years
51%
|
CAGR 5-Years
27%
|
CAGR 10-Years
N/A
|
L
|
LegoChem Biosciences Inc
KOSDAQ:141080
|
EPS (Diluted)
-₩2.6k
|
CAGR 3-Years
-104%
|
CAGR 5-Years
-16%
|
CAGR 10-Years
-21%
|
See Also
What is Samsung Biologics Co Ltd's EPS (Diluted)?
EPS (Diluted)
12.1k
KRW
Based on the financial report for Dec 31, 2023, Samsung Biologics Co Ltd's EPS (Diluted) amounts to 12.1k KRW.
What is Samsung Biologics Co Ltd's EPS (Diluted) growth rate?
EPS (Diluted) CAGR 5Y
29%
Over the last year, the EPS (Diluted) growth was 5%. The average annual EPS (Diluted) growth rates for Samsung Biologics Co Ltd have been 49% over the past three years , 29% over the past five years .